Moffitt Cancer Center-International Plaza is a clinical research site located in Tampa, Florida, United States 33607.
Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.
Moffitt Cancer Center-International Plaza has participated in 74 clinical trials with 64 currently active.
Therapeutic areas: Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Metastatic Malignant Neoplasm in the Brain, Retroperitoneal Sarcoma.
Sponsors: SWOG Cancer Research Network, NRG Oncology, European Organisation for Research and Treatment of Cancer - EORTC.
Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Moffitt Cancer Center-International Plaza has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Moffitt Cancer Center-International Plaza has 74 clinical trials on record, with 64 currently active. Their work covers Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Metastatic Malignant Neoplasm in the Brain, Retroperitoneal Sarcoma.
Yes — Moffitt Cancer Center-International Plaza holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.